Averride MP 1mg/500mg/15mg Tablet SR
Marketer
Altrawell Biotech Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Averride MP 1mg/500mg/15mg Tablet SR
A single tablet of Averride MP SR (1mg/500mg/15mg) combines medications to effectively manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this formulation enhances insulin efficiency, resulting in improved blood sugar control. Always adhere to your physician's prescribed dosage and regimen; taking it with food minimizes stomach discomfort. A missed dose should be taken promptly unless your next dose is imminent; never double the dose. Excessive intake can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases the hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should also seek medical advice. Kidney function tests are typically performed before initiating treatment. Limit alcohol consumption to mitigate potential side effects.
Uses of Averride MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Averride MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Averride MP 1mg/500mg/15mg Extended-Release tablets should be taken with meals.
Common Side effects of Averride MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Averride MP 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; do not chew, crush, or fracture it. Consume Averride MP 1mg/500mg/15mg Extended-Release tablets with food.
How Averride MP 1mg/500mg/15mg Tablet SR works:
Averride MP 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their complementary mechanisms improve blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Averride MP 1mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Averride MP 1mg/500mg/15mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Use of Averride MP 1mg/500mg/15mg SR tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Averride MP 1mg/500mg/15mg Tablet SR, potentially requiring dosage modification. Physician consultation is advised. Averride MP 1mg/500mg/15mg Tablet SR is contraindicated in patients experiencing severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Averride MP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. Averride MP 1mg/500mg/15mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Averride MP 1mg/500mg/15mg Tablet SR :
Should you forget a dose of Averride MP 1mg/500mg/15mg Tablet SR, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Averride MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
3,018 People bought this recently